ZA200108206B - Oral pharmaceutical ibuprofen suspension. - Google Patents

Oral pharmaceutical ibuprofen suspension.

Info

Publication number
ZA200108206B
ZA200108206B ZA200108206A ZA200108206A ZA200108206B ZA 200108206 B ZA200108206 B ZA 200108206B ZA 200108206 A ZA200108206 A ZA 200108206A ZA 200108206 A ZA200108206 A ZA 200108206A ZA 200108206 B ZA200108206 B ZA 200108206B
Authority
ZA
South Africa
Prior art keywords
oral pharmaceutical
ibuprofen suspension
pharmaceutical ibuprofen
suspension
oral
Prior art date
Application number
ZA200108206A
Inventor
Christophe Lebon
Emmanuel Guerin
Pascal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of ZA200108206B publication Critical patent/ZA200108206B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200108206A 1999-04-06 2001-10-05 Oral pharmaceutical ibuprofen suspension. ZA200108206B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904251A FR2791888B1 (en) 1999-04-06 1999-04-06 ORAL PHARMACEUTICAL SUSPENSION

Publications (1)

Publication Number Publication Date
ZA200108206B true ZA200108206B (en) 2002-12-24

Family

ID=9544041

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200108116A ZA200108116B (en) 1999-04-06 2001-10-03 Drinkable pharmaceutical solution.
ZA200108206A ZA200108206B (en) 1999-04-06 2001-10-05 Oral pharmaceutical ibuprofen suspension.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA200108116A ZA200108116B (en) 1999-04-06 2001-10-03 Drinkable pharmaceutical solution.

Country Status (9)

Country Link
EP (1) EP1165043A1 (en)
CN (1) CN1351488A (en)
AU (1) AU778364B2 (en)
BR (1) BR0009551A (en)
FR (1) FR2791888B1 (en)
HU (1) HUP0200711A3 (en)
IL (1) IL145768A0 (en)
WO (1) WO2000059468A1 (en)
ZA (2) ZA200108116B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1411899T3 (en) * 2001-08-01 2009-06-02 Novartis Ag Taste-masking composition
US7300670B2 (en) * 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
KR20170052626A (en) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
DE3900811A1 (en) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh NEW MEDICINE
IE902829A1 (en) * 1989-08-14 1991-02-27 Eurand America Microencapsulated taste-masked water-insoluble nsaid drug¹materials
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine coatings for taste-masking orally administrable medicaments
EP0717992A3 (en) * 1994-12-21 1998-03-25 McNEIL-PPC, INC. Aqueous suspension formulations for pharmaceutical applications
EP0830135A1 (en) * 1995-05-09 1998-03-25 The Procter & Gamble Company Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders

Also Published As

Publication number Publication date
EP1165043A1 (en) 2002-01-02
AU3825200A (en) 2000-10-23
FR2791888A1 (en) 2000-10-13
HUP0200711A2 (en) 2002-07-29
BR0009551A (en) 2002-05-28
AU778364B2 (en) 2004-12-02
CN1351488A (en) 2002-05-29
ZA200108116B (en) 2002-09-25
HUP0200711A3 (en) 2003-04-28
WO2000059468A1 (en) 2000-10-12
FR2791888B1 (en) 2004-10-08
IL145768A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
ZA200202480B (en) Oral dosage forms.
HK1034455A1 (en) Oral pharmaceutical extended release dosage form.
HK1045650A1 (en) Pharmaceutical composition.
ZA200105407B (en) Taste-Masked Pharmaceutical Particles.
ZA993338B (en) Pharmaceutical formulations.
ZA200107123B (en) Oral drug delivery system.
MXPA01012478A (en) Improved pharmaceutical formulations.
PL351686A1 (en) Novel pharmaceutical
ZA200203707B (en) Pharmaceutical combinations.
ZA200000857B (en) Pharmaceutical composition.
EG23858A (en) Drug combination
EG23937A (en) Novel pharmaceutical
HK1046140A1 (en) Solid pharmaceutical preparation
HK1040488A1 (en) Pharmaceutical formulations.
EP1173216A4 (en) Pharmaceutical formulations
IL146152A0 (en) Prucalopride oral solution
GB9909041D0 (en) Novel pharmaceutical
ZA200110454B (en) Pharmaceutical complex.
EG23946A (en) Novel pharmaceutical
ZA200108206B (en) Oral pharmaceutical ibuprofen suspension.
HK1046133A1 (en) Pharmaceutical compounds.
GB9906126D0 (en) Pharmaceutical formulations
GB9930578D0 (en) Pharmaceutical formulations
GB9923933D0 (en) Novel pharmaceutical
GB9923934D0 (en) Novel pharmaceutical